AB9890
Anti-AGE (Advanced Glycation End-products) Antibody
serum, Chemicon®
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Scegli un formato
200 μL
534,00 €
Scegli un formato
Cambia visualizzazione
200 μL
534,00 €
About This Item
Codice UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Prodotti consigliati
Origine biologica
goat
Livello qualitativo
Forma dell’anticorpo
serum
Tipo di anticorpo
primary antibodies
Clone
polyclonal
Reattività contro le specie
human
Produttore/marchio commerciale
Chemicon®
tecniche
ELISA: suitable
western blot: suitable
Condizioni di spedizione
wet ice
modifica post-traduzionali bersaglio
unmodified
Specificità
AGE (Advanced Glycation End-products)
Immunogeno
Glycoaldehyde-modified protein.
Applicazioni
Anti-AGE (Advanced Glycation End-products) Antibody detects level of AGE (Advanced Glycated End-products) & has been published & validated for use in ELISA & WB.
Research Category
Neuroscience
Neuroscience
Research Sub Category
Neurodegenerative Diseases
Oxidative Stress
Neurodegenerative Diseases
Oxidative Stress
Western blot: ≥1:2,000 on AGE-modified proteins.
ELISA: ≥ 1:4,000 against Glycoaldehyde-modified BSA.
Optimal working dilutions must be determined by end user.
ELISA: ≥ 1:4,000 against Glycoaldehyde-modified BSA.
Optimal working dilutions must be determined by end user.
Stato fisico
Goat antiserum. Liquid with 0.1% SODIUM AZIDE
Serum
Stoccaggio e stabilità
Maintain at -20°C in undiluted aliquots for up to 12 months after date of receipt. Avoid repeated freeze/thaw cycles.
Note legali
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Esclusione di responsabilità
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Non trovi il prodotto giusto?
Prova il nostro Motore di ricerca dei prodotti.
Codice della classe di stoccaggio
12 - Non Combustible Liquids
Classe di pericolosità dell'acqua (WGK)
WGK 1
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Ali S Alqahtani et al.
Saudi journal of biological sciences, 28(1), 813-824 (2021-01-12)
Current pre-clinical evidences of Centella focus on its pharmacological effects on normal wound healing but there are limited studies on the bioactivity of Centella in cellular dysfunction associated with diabetic wounds. Hence we planned to examine the potential of Centella
Amit Garg et al.
ACS pharmacology & translational science, 6(2), 253-269 (2023-02-18)
Advanced glycation end-products (AGEs) form when glucose reacts non-enzymatically with proteins, leading to abnormal protein function, oxidative stress, and inflammation. AGEs are associated with aging and age-related diseases; their formation is aggravated during diabetes. Therefore, drugs preventing AGE formation can
Shweta Kishor Sonawane et al.
Oncotarget, 12(11), 1083-1099 (2021-06-05)
Alzheimer's disease is a type of dementia denoted by progressive neuronal death due to the accumulation of proteinaceous aggregates of Tau. Post-translational modifications like hyperphosphorylation, truncation, glycation, etc. play a pivotal role in Tau pathogenesis. Glycation of Tau aids in
Vassilis L Tzounakas et al.
Frontiers in medicine, 5, 16-16 (2018-02-21)
Transfusion of fresh frozen plasma (FFP) helps in maintaining the coagulation parameters in patients with acquired multiple coagulation factor deficiencies and severe bleeding. However, along with coagulation factors and procoagulant extracellular vesicles (EVs), numerous bioactive and probably donor-related factors (metabolites
Hugo Vicente Miranda et al.
Brain : a journal of neurology, 140(5), 1399-1419 (2017-04-12)
α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases known as synucleinopathies. The toxic properties of α-synuclein are conserved from yeast to man, but the precise underpinnings of the cellular pathologies associated are
Filtri attivi
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.
